-
1.
公开(公告)号:US5567698A
公开(公告)日:1996-10-22
申请号:US454058
申请日:1995-05-30
申请人: Choung U. Kim , Peter F. Misco, Jr. , John A. Wichtowski , Yasutsugu Ueda , Thomas W. Hudyma , John D. Matiskella , Stanley V. D'Andrea , Shelley E. Hoeft , Raymond F. Miller , Muzammil M. Mansuri , Joanne J. Bronson
发明人: Choung U. Kim , Peter F. Misco, Jr. , John A. Wichtowski , Yasutsugu Ueda , Thomas W. Hudyma , John D. Matiskella , Stanley V. D'Andrea , Shelley E. Hoeft , Raymond F. Miller , Muzammil M. Mansuri , Joanne J. Bronson
IPC分类号: A61K31/545 , A61K31/546 , A61P31/04 , C07D501/00 , C07D501/36 , A61K31/43 , C07D501/60
CPC分类号: C07D501/00
摘要: Novel cephem derivatives represented by the general formula ##STR1## in which the Acyl substituent is a group of the formula ##STR2## wherein Ar is a lipophilic optionally substituted phenyl, naphthyl, pyridyl or benzthiazolyl group; R.sup.1 is selected from certain optionally substituted aliphatic, aromatic, arylaliphatic or sugar moieties and R.sup.2 and R.sup.3 are each independently hydrogen, alkyl or aminoalkylcarbonylamino are gram-positive antibacterial agents, especially useful in the treatment of infectious diseases caused by methicillin-resistant Staphylococcus aureus (MRSA).
摘要翻译: 由通式
表示的新型头孢烯衍生物,其中酰基取代基是式IMA的组,其中Ar是亲脂性任选取代的苯基,萘基,吡啶基或苯并噻唑基; R1选自某些任选取代的脂族,芳族,芳基脂族或糖部分,R2和R3各自独立地为氢,烷基或氨基烷基羰基氨基为革兰氏阳性抗菌剂,特别可用于治疗由耐甲氧西林金黄色葡萄球菌引起的感染性疾病( MRSA)。 -
公开(公告)号:US5668284A
公开(公告)日:1997-09-16
申请号:US644751
申请日:1996-05-08
申请人: Choung U. Kim , Peter F. Misco, Jr. , John A. Wichtowski , Yasutsugu Ueda , Thomas W. Hudyma , John D. Matiskella , Stanley V. D'Andrea , Shelley E. Hoeft , Raymond F. Miller , Muzammil M. Mansuri , Joanne J. Bronson
发明人: Choung U. Kim , Peter F. Misco, Jr. , John A. Wichtowski , Yasutsugu Ueda , Thomas W. Hudyma , John D. Matiskella , Stanley V. D'Andrea , Shelley E. Hoeft , Raymond F. Miller , Muzammil M. Mansuri , Joanne J. Bronson
IPC分类号: A61K31/545 , A61K31/546 , A61P31/04 , C07D501/00 , C07D501/36 , C07D211/84 , C07F9/58
CPC分类号: C07D501/00
摘要: Novel cephem derivatives represented by the general formula ##STR1## in which the Acyl substituent is a group of the formula ##STR2## wherein Ar is a lipophilic optionally substituted phenyl, naphthyl, pyridyl or benzthiazolyl group; R.sup.1 is selected from certain optionally substituted aliphatic, aromatic, arylaliphatic or sugar moieties and R.sup.2 and R.sup.3 are each independently hydrogen, alkyl or aminoalkylcarbonylamino are gram-positive antibacterial agents, especially useful in the treatment of infectious diseases caused by methicillin-resistant Staphylococcus aureus (MRSA).
摘要翻译: 由通式
表示的新型头孢烯衍生物,其中酰基取代基是式IMA的组,其中Ar是亲脂性任选取代的苯基,萘基,吡啶基或苯并噻唑基; R1选自某些任选取代的脂族,芳族,芳基脂族或糖部分,R2和R3各自独立地为氢,烷基或氨基烷基羰基氨基是革兰氏阳性抗菌剂,特别可用于治疗由耐甲氧西林金黄色葡萄球菌引起的感染性疾病( MRSA)。 -
公开(公告)号:US5559108A
公开(公告)日:1996-09-24
申请号:US445628
申请日:1995-05-22
申请人: Choung U. Kim , Muzammil M. Mansuri , Peter F. Misco, Jr. , John A. Wichtowski , Joanne J. Bronson , Stanley V. D'Andrea , Thomas W. Hudyma
发明人: Choung U. Kim , Muzammil M. Mansuri , Peter F. Misco, Jr. , John A. Wichtowski , Joanne J. Bronson , Stanley V. D'Andrea , Thomas W. Hudyma
IPC分类号: C07D501/40 , A61K31/545 , A61K31/546 , A61P31/04 , C07D501/00 , C07D501/44 , C07D501/46 , C07D501/38
CPC分类号: C07D501/00
摘要: Novel cephem derivatives represented by the general formula ##STR1## in which the Acyl substituent is a group of the formula ##STR2## where Ar is a substituted phenyl or optionally substituted naphthyl or benzthiazolyl group and A is a substituted-pyridinium group are gram-positive antibiotics, especially useful in the treatment of diseases caused by methicillin-resistant Staphylococcus aureus.
摘要翻译: 由通式“IMAGE”表示的新型头孢烯衍生物,其中酰基取代基是式IMAMA的基团,其中Ar是取代的苯基或任选被取代的萘基或苯并噻唑基,A是取代的吡啶鎓基是革兰氏阳性 抗生素,特别适用于治疗由耐甲氧西林金黄色葡萄球菌引起的疾病。
-
公开(公告)号:US5436369A
公开(公告)日:1995-07-25
申请号:US200798
申请日:1994-02-23
申请人: Joanne J. Bronson , Katharine M. Greene , Muzammil M. Mansuri , Stanley V. D'Andrea , F. Ivy Carroll , Anita Lewin
发明人: Joanne J. Bronson , Katharine M. Greene , Muzammil M. Mansuri , Stanley V. D'Andrea , F. Ivy Carroll , Anita Lewin
IPC分类号: C07C69/612 , A61K31/19 , A61P29/00 , C07C63/66 , C07C67/30 , C07C69/00 , C07C69/618 , C07C69/65 , C07C69/734 , C07C69/76 , C07C69/94 , C07C63/64
CPC分类号: C07C63/66 , C07C69/618 , C07C69/65 , C07C69/734 , C07C69/76 , C07C69/94 , C07C2103/74
摘要: Certain novel alicyclic compounds are effective phospholipase A.sub.2 (PLA.sub.2) inhibitors.
摘要翻译: 某些新型脂环化合物是有效的磷脂酶A2(PLA2)抑制剂。
-
公开(公告)号:US5744600A
公开(公告)日:1998-04-28
申请号:US357561
申请日:1994-12-16
IPC分类号: C07F9/6512 , A61K31/675 , C07F9/6561 , C07D473/18 , C07D473/34
CPC分类号: C07F9/65121
摘要: A compound of the Formula I or Formula II ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen, hydroxy, chlorine, fluorine, bromine, or an organic substituent having 1 to 5 carbon atoms and selected from acyloxy having a hydrocarbon stem of 1 to 4 carbon atoms, alkoxy, alkylthio, amino, alkylamino and dialkylamino; R.sup.3 and R.sup.4 are independently hydrogen, or organic phosphonic ester substituents having 1 to 12 carbon atoms and selected from alkyl, alkenyl, aryl, and aralkyl; and B is a heterocyclic group selected from the group consisting of pyrimidine, purine, triazine, deazapurine, and triazole, attached through a ring nitrogen atom thereof optionally substituted with 1 to 3 substituents selected from the group consisting of hydroxy, mercapto, amino, hydrazino, fluoro, chloro, bromo, iodo, C.sub.1 to C.sub.3 alkyl, C2-C3 alkenyl, C2-C3 haloalkenyl, C1-C3 alkoxy, and C1-C3 alkylthio; and the pharmaceutically acceptable acid addition, metal, and amine salts thereof. The compositions of the invention are useful for, among other things, antiviral agents.
摘要翻译: 式I或式II的化合物其中R 1和R 2独立地是氢,羟基,氯,氟,溴或具有1至5个碳原子并且选自具有烃的酰氧基的有机取代基 1至4个碳原子的烷氧基,烷硫基,氨基,烷基氨基和二烷基氨基; R3和R4独立地是氢,或具有1至12个碳原子并且选自烷基,烯基,芳基和芳烷基的有机膦酸酯取代基; 并且B是选自嘧啶,嘌呤,三嗪,脱氮嘌呤和三唑的杂环基,其通过环氮原子连接,任选被1-3个选自羟基,巯基,氨基,肼基的取代基取代 ,氟,氯,溴,碘,C 1至C 3烷基,C 2 -C 3烯基,C 2 -C 3卤代烯基,C 1 -C 3烷氧基和C 1 -C 3烷硫基; 及其药学上可接受的酸加成盐,金属盐和胺盐。 本发明的组合物尤其可用于抗病毒剂。
-
公开(公告)号:US5734047A
公开(公告)日:1998-03-31
申请号:US761738
申请日:1996-12-05
IPC分类号: C07D501/00 , C07D501/36 , A61K31/545
CPC分类号: C07D501/00
摘要: Novel cephem derivatives represented by the general formula ##STR1## wherein Ar is an optionally substituted lipophilic phenyl, naphthyl, benzthiazolyl or pyridyl group; R.sup.1 represents a group of the formula ##STR2## in which R.sup.8 and R.sup.9 are each independently hydrogen, C.sub.1 -C.sub.6 alkyl or (C.sub.1 -C.sub.6)alkoxycarbonyl, said C.sub.1 -C.sub.6 alkyl group being optionally substituted by 1-5 hydroxy or C.sub.1 -C.sub.6 alkoxy groups; m is either 0 or 1; A is a C.sub.2 -C.sub.10 alkyl group optionally substituted by 1-5 hydroxy groups; and R.sup.2 and R.sup.3 are each independently hydrogen or C.sub.1 -C.sub.6 alkyl. The derivatives are gram-positive antibacterial agents especially useful in the treatment of diseases caused by methicillin-resistant Staphylococcus aureus.
摘要翻译: 由通式
+ TR 表示的新型头孢烯衍生物,其中Ar是任选取代的亲脂性苯基,萘基,苯并噻唑基或吡啶基; R 1表示式(VIII)的基团,其中R 8和R 9各自独立地为氢,C 1 -C 6烷基或(C 1 -C 6)烷氧基羰基,所述C 1 -C 6烷基任选被1-5个羟基或C 1 -C 6 烷氧基 m为0或1; A是任选被1-5个羟基取代的C 2 -C 10烷基; 且R 2和R 3各自独立地为氢或C 1 -C 6烷基。 衍生物是革兰氏阳性抗菌剂,特别适用于治疗耐甲氧西林金黄色葡萄球菌引起的疾病。 -
公开(公告)号:US5391817A
公开(公告)日:1995-02-21
申请号:US171038
申请日:1993-12-21
IPC分类号: A61K31/19 , A61K31/215 , A61K31/235 , A61P29/00 , C07C43/215 , C07C43/225 , C07C43/23 , C07C45/67 , C07C45/70 , C07C45/71 , C07C47/57 , C07C47/575 , C07C59/72 , C07C63/331 , C07C63/49 , C07C63/66 , C07C63/74 , C07C65/24 , C07C65/26 , C07C65/28 , C07C65/34 , C07C69/00 , C07C69/017 , C07C69/65 , C07C69/73 , C07C69/732 , C07C69/734 , C07C69/76 , C07C69/94 , C07C205/56 , C07C233/65 , C07C309/65 , C07C317/44 , C07F9/38 , C07C59/40
CPC分类号: C07C309/65 , C07C43/215 , C07C43/225 , C07C43/23 , C07C45/673 , C07C45/70 , C07C45/71 , C07C47/57 , C07C47/575 , C07C59/72 , C07C63/49 , C07C63/66 , C07C65/24 , C07C65/26 , C07C65/28 , C07C69/00 , C07C69/017 , C07C69/734 , C07C69/76 , C07C69/94 , C07C2102/10 , C07C2103/00 , C07C2103/74
摘要: Certain novel biaryl compounds are effective phospholipase A.sub.2 (PLA.sub.2) inhibitors.
摘要翻译: 某些新型联芳化合物是有效的磷脂酶A2(PLA2)抑制剂。
-
公开(公告)号:US5792756A
公开(公告)日:1998-08-11
申请号:US481715
申请日:1995-06-07
申请人: John E. Starrett, Jr. , Muzammil M. Mansuri , John C. Martin , David R. Tortolani , Joanne J. Bronson
发明人: John E. Starrett, Jr. , Muzammil M. Mansuri , John C. Martin , David R. Tortolani , Joanne J. Bronson
IPC分类号: A61K31/675 , A61K31/66 , A61K31/70 , A61P31/12 , A61P35/00 , C07F9/6512 , C07F9/6561 , C07F9/6571 , C07F9/6574 , C07F9/6584 , C07H13/10 , C07H19/10 , C07H19/20 , C07F9/02
CPC分类号: C07F9/65742 , C07F9/65121 , C07F9/65616 , C07F9/657181 , C07F9/6584
摘要: There are disclosed novel oral prodrugs of phosphonate nucleotide analogs which are hydrolyzable under physiological conditions to yield compounds which are useful as antiviral agents, especially as agents effective against RNA and DNA viruses. They may also find use as antitumor agents.
摘要翻译: 公开了在生理条件下可水解的新型口服前药的膦酸酯核苷酸类似物,以产生可用作抗病毒剂的化合物,特别是作为对RNA和DNA病毒有效的试剂。 它们也可以用作抗肿瘤剂。
-
公开(公告)号:US5663159A
公开(公告)日:1997-09-02
申请号:US320632
申请日:1994-10-11
申请人: John E. Starrett, Jr. , Muzammil M. Mansuri , John C. Martin , David R. Tortolani , Joanne J. Bronson
发明人: John E. Starrett, Jr. , Muzammil M. Mansuri , John C. Martin , David R. Tortolani , Joanne J. Bronson
IPC分类号: A61K31/675 , A61K31/66 , A61K31/70 , A61P31/12 , A61P35/00 , C07F9/6512 , C07F9/6561 , C07F9/6571 , C07F9/6574 , C07F9/6584 , C07H13/10 , C07H19/10 , C07H19/20
CPC分类号: C07F9/65742 , C07F9/65121 , C07F9/65616 , C07F9/657181 , C07F9/6584
摘要: There are disclosed novel oral prodrugs of phosphonate nucleotide analogs which are hydrolyzable under physiological conditions to yield compounds which are useful as antiviral agents, especially as agents effective against RNA and DNA viruses. They may also find use as antitumor agents.
摘要翻译: 公开了在生理条件下可水解的新型口服前药的膦酸酯核苷酸类似物,以产生可用作抗病毒剂的化合物,特别是作为对RNA和DNA病毒有效的试剂。 它们也可以用作抗肿瘤剂。
-
公开(公告)号:US5218106A
公开(公告)日:1993-06-08
申请号:US857850
申请日:1992-03-26
IPC分类号: A61K31/70 , A61K31/7042 , A61K31/7052 , A61K31/7056 , A61K31/7064 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61P31/12 , C07H19/04 , C07H19/056 , C07H19/06 , C07H19/16 , C07H19/19
摘要: There are disclosed novel 2',3'-dideoxy-2'-fluoronucleosides and 2'-3'-dideoxy-2',3'-didehydro-2'-fluoronucleosides and processes for their preparation. The compounds so produced exhibit therapeutically useful antiviral and, more particularly, anti-HIV effects.
摘要翻译: 公开了新的2',3'-二脱氧-2'-氟核苷和2'-3'-二脱氧-2',3'-二脱氢-2'-氟核苷及其制备方法。 如此制备的化合物显示出治疗上有用的抗病毒,更具体地,抗HIV作用。
-
-
-
-
-
-
-
-
-